학술논문
Iberdomide in patients with systemic lupus erythematosus: A randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
Document Type
Article
Author
Source
In: Lupus Science and Medicine . (Lupus Science and Medicine, 15 February 2022, 9(1))
Subject
Language
English
ISSN
20538790